shutterstock_1386380144_ingus_kruklitis
Ingus Kruklitis / Shutterstock.com
4 June 2019

C5’s 18th International forum on Pharmaceutical Patent Term Extensions

Don’t miss this opportunity to join the European Commission, European Patent Office, German, Netherland, and Portuguese patent offices, and leading pharmaceutical in-house decision makers to tackle current pharma patent term extensions challenges in Europe and worldwide at C5’s 18th International forum on Pharmaceutical Patent Term Extensions in Munich, June 25 & 26.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
23 March 2026   With Novo Nordisk's core semaglutide patent expired in India last week, the company that built one of the most successful drugs in pharmaceutical history is already fighting on a new front. So what comes next?
Asia
20 March 2026   As the patent protecting semaglutide—the drug that made Novo Nordisk one of Europe's most valuable companies—expires in ten countries, the pressure mounts for prices and market leaders alike.
Americas
19 March 2026   Although the court agreed that the tech giant misappropriated some of Masimo’s information related to pulse oximetry technology, Apple is not barred from using it, says a California judge.